(Q38125275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

6 March 2020

main subject

0 references

author

Elizabeth J. Ryan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Glen A Doherty

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

David J Gibson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

1 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

2716-2724

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Intestinal homeostasis and its breakdown in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Critical role of caspases in the regulation of apoptosis and proliferation of mucosal T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Foxp3 in control of the regulatory T cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Control of regulatory T cell lineage commitment and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Induction of colonic regulatory T cells by indigenous Clostridium species

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Toll-like receptor 2 controls expansion and function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

The role of inflammasome-derived IL-1 in driving IL-17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Development of inflammatory bowel disease in Long-Evans Cinnamon rats based on CD4+CD25+Foxp3+ regulatory T cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Future biologic targets for IBD: potentials and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Regulation of gut inflammation and th17 cell response by interleukin-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

CTLA-4 control over Foxp3+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

In vitro Treg suppression assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Mouse and human intestinal immunity: same ballpark, different players; different rules, same score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Plasticity of T reg at infected sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Ustekinumab induction and maintenance therapy in refractory Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829ED7DF

10.1097/MIB.0B013E31829ED7DF

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23899545%20AND%20SRC:MED&resulttype=core&format=json

release_tc752g2uynf5ng6lcef4uhgwti

6 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tc752g2uynf5ng6lcef4uhgwti

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference